Infant Bacterial Therapeutics AB (publ) IFTBF 价格预测与展望

Q: 技术分析指标如何适用于 IFTBF？

根据技术分析，Infant Bacterial Therapeutics AB (publ) 的综合信号为 Neutral。Infant Bacterial Therapeutics AB (publ) 有 0 个买入信号，7 个中性信号和 0 个卖出信号。

Q: IFTBF 的斐波那契回调水平是多少？

Infant Bacterial Therapeutics AB (publ) 的斐波那契回调水平是 在 0% 和 23.6% 之间。

Q: Infant Bacterial Therapeutics AB (publ) 的 RSI 是多少？

Infant Bacterial Therapeutics AB (publ) 的 RSI 目前为 NaN，表明处于 中立 状态

Q: Infant Bacterial Therapeutics AB (publ) 接下来 12 个月的价格是多少？

Infant Bacterial Therapeutics AB (publ) IFTBF 接下来 12 个月的价格预计为 $0。

Q: Infant Bacterial Therapeutics AB (publ) 预计会涨到多高？

据华尔街分析师称，Infant Bacterial Therapeutics AB (publ) 预计将达到 $0 的高预测值。

主页

股票

IFTBF

预测

IFTBF 股票价格预测

Infant Bacterial Therapeutics AB (publ)

$5.47

14.43%

$0.68

截至今日：Jan 29, 14:39:27 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

$4.78

开盘价

$5.47

当日区间

$5.47 - $5.47

52周范围

$4.78 - $8.2

交易量

平均成交量

1.0K

每股收益（TTM）

股息收益率

市值

$71.2M

什么是 INFANT BACTERIAL THERAPEUTICS A？

Infant Bacterial Therapeutics AB is a clinical stage pharmaceutical company, which engages in the development of drugs for the treatment of rare diseases affecting premature infants. The company is headquartered in Stockholm, Stockholm and currently employs 10 full-time employees. The company went IPO on 2016-03-29. The firm develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of necrotizing enterocolitis (NEC), a fatal disease that affects premature infants.

功能特性

交易策略

资源

市场

IFTBF 股价预测摘要

IFTBF的顶级分析师评级

基于 9 位分析师对 IFTBF 的股票评级，更新于 Dec 01, 2021

Strong Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for IFTBF. Our analysts highlight strong fundamentals and favorable market sentiment, positioning IFTBF for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: IFTBF is a Strong Buy candidate.

IFTBF stock price ended at $5.47 on 星期四, after rising 14.44%

On the latest trading day Jan 08, 2026, the stock price of IFTBF rose by 14.44%, climbing from $5.47 to $5.47. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $5.47 and a high of $5.47. Alongside this price increase, trading volume also rose by 348 shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 852 shares were traded, amounting to a market value of approximately $71.2M.

IFTBF 技术面信号

技术面信号摘要

购买信号 0

中性信号 7

卖出信号 0

Strong Sell

Sell

Neutral

Buy

Strong Buy

IFTBF目前显示0个买入信号和0个卖出信号。该股票自12:00 AM以来一直处于上升趋势状态，在此期间价格总变动为14.44%。总体而言，技术指标显示中期前景为Neutral。

IFTBF 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 IFTBF 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 IFTBF？



IFTBF 的斐波那契回调水平是多少？



Infant Bacterial Therapeutics AB (publ) 的 RSI 是多少？



Infant Bacterial Therapeutics AB (publ) 接下来 12 个月的价格是多少？



Infant Bacterial Therapeutics AB (publ) 预计会涨到多高？



Infant Bacterial Therapeutics AB (publ)（IFTBF）价格

IFTBF 股价走势图